| Acquirer | Target | Price |
|---|---|---|
| Juno Therapeutics, Inc. | AbVitro, Inc. | $122.8 million |
| Satellite Healthcare, Inc. | 3 dialysis centers | N/A |
| MiMedix Group Inc. | Stability Biologics | $10 million |
| Shire plc | Baxalta Inc. | $32 billion |
| Roche | Tensha Therapeutics | $115 million |
| U.S. HealthWorks | Muir/Diablo Occupational Medicine | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
